Rivaroxaban in acute venous thromboembolism: UK prescribing experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rivaroxaban in acute venous thromboembolism: UK prescribing experience

Published:2021-10 Issue:7 Volume:5 Page:
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Speed Victoria¹²^ORCID,Patel Jignesh P.¹²^ORCID,Cooper Derek³,Miller Stephen⁴,Roberts Lara N.¹^ORCID,Patel Raj K.¹,Arya Roopen¹^ORCID

Affiliation:

1. Department of Haematological Medicine King's Thrombosis Centre King's College Hospital NHS Foundation Trust London UK

2. UK Institute of Pharmaceutical Sciences King’s College London London UK

3. King’s College London London UK

4. Progeny Europe (Windward Systems Ltd.) Norfolk UK

Funder

Bayer HealthCare

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12607

Reference44 articles.

1. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

2. New oral anticoagulants: dosing and monitoring

3. Are New Oral Anticoagulant Dosing Recommendations Optimal for All Patients?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Different Anticoagulation Regimens for Deep Vein Thrombosis in Real Clinical Practice;Journal of Venous Disorders;2024

2. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism;Thrombosis Update;2023-12

3. Risk of Bleeding Associated With Outpatient Use of Rivaroxaban in VTE Management at a National Referral Hospital in Western Kenya;Clinical and Applied Thrombosis/Hemostasis;2023-01

4. Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry;Research and Practice in Thrombosis and Haemostasis;2022-10

5. Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry;Research and Practice in Thrombosis and Haemostasis;2021-11-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3